Search Results

Pedra Technology’s Xauron Tissue Perfusion System Receives FDA Breakthrough Device Designation

January 25, 2021—Pedra Technology announced that the FDA has granted the company a Breakthrough Device designation for the periprocedural use of its Xauron perfusion system in patients treated for chronic limb-threatening ischemia.

ALTITUDE Global Registry Will Evaluate Lombard Medical's Altura EVAR Device in Real World Patients

June 16, 2016—Lombard Medical, Inc. announced plans to conduct a global registry to evaluate its new Altura endograft system for the endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs).

Lombard Medical Begins ALTITUDE Enrollment in United Kingdom

May 15, 2017—Lombard Medical, Inc. announced that it has enrolled and treated the first patient in the company's ALTITUDE global registry to evaluate its Altura endograft system for the endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs).

Presentations Feature Lombard Medical's Altura and Aorfix EVAR Systems

May 4, 2017—Lombard Medical, Inc. announced that the company's Altura and Aorfix endovascular stent graft systems were featured in presentations at the 39th annual Charing Cross International Symposium, which was held April 25–28 in London, United Kingdom.  Five-year clinical data on the Altura device, combined from two prospective, international, multicenter studies were presented by Prof.